What does medsurg — purchase accounting adjustments mean?

Includes non-cash accounting adjustments arising from the acquisition of assets or businesses within the MedSurg segment, such as the step-up in inventory or intangible asset values. These adjustments are essential for reconciling reported segment performance with underlying operational cash flows.

Haemonetics (HAE) MedSurg — Purchase accounting adjustments

Screener

Other segment segments

Apheresis

$0—

Similar metrics at other companies

STCTitle — Purchase accounting adjustments

-$117K—

ZDCybersecurity & Martech — Purchase accounting adjustments

$0+100%

ZDGaming & Entertainment — Purchase accounting adjustments

-$171K-456%

ZDHealth & Wellness — Purchase accounting adjustments

-$437K—

ZDTechnology & Shopping — Purchase accounting adjustments

$0+100%

CORInternational Healthcare Solutions — Purchase accounting adjustments

$0—

Other financials

Income statement

See full

Revenue$339.4M+5.6%

Gross profit$202.8M+5.5%

Operating income$57.5M+6.7%

Net income$33.0M-3.0%

EPS (diluted)$0.72+2.9%

Balance sheet

See full

Cash & equivalents$223.4M-23.7%

Total debt$1.2B-4.1%

Total equity$837.1M-5.1%

Total assets$2.4B-3.9%

Cash flow

See full

Operating cash flow$52.3M+201%

CapEx$7.9M+111%

Free cash flow$44.4M+226%

Valuation

See full

Market cap$3.8B+4.4%

Enterprise value$4.75B+3.9%

P/E25.3×-10.3×

P/S2.8×+0.1×

Profitability

See full

Gross margin59%+2.1pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin21.5%+7.5pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.4×0.0×

Current ratio3.1×+1.4×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:GoodwillPurchaseAccountingAdjustments.

The source filing: Haemonetics’s 10-Q, filed August 6, 2026.

Filed: Aug 6, 2026, 6:09 AM EDT
Fiscal quarter: Q1 FY2027
Calendar quarter: Q2 2026
Accession: 0000313143-26-000120

Line item	Apheresis	Med Surg	Total
Carrying amount as of March 28, 2026	$55,931	$600,437	$656,368
Purchase accounting adjustments	—	1,714	1,714
Currency translation	(22)	(1,176)	(1,198)
Carrying amount as of June 27, 2026	$55,909	$600,975	$656,884

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Haemonetics's medsurg — purchase accounting adjustments?: Haemonetics (HAE) reported medsurg — purchase accounting adjustments of $1.71M in Q2 2026.
What does medsurg — purchase accounting adjustments mean?: Includes non-cash accounting adjustments arising from the acquisition of assets or businesses within the MedSurg segment, such as the step-up in inventory or intangible asset values. These adjustments are essential for reconciling reported segment performance with underlying operational cash flows.